Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nayana Ingole"'
Autor:
Abhinendra Kumar, Lekshmi S. Rajan, Kannan Sabarinath PS, Anita M. Shete, Rima R. Sahay, Deepak Y. Patil, Nayana Ingole, Kaveri K, Anupama Cherayi Padinakarai, Shantala GB, Jayanthi Shastri, Shashiraja Padukone, Yash Joshi, Savita Patil, Triparna Majumdar, Ajay Verma, Jyoti Yemul, Nandini Shende, Vaishnavi Kumari, Pratiksha Vedpathak, Shubhangi Sathe, Pranita Gawande, Pragya D. Yadav
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground The multi-country mpox outbreak across the globe has led to the systematic surveillance of mpox cases in India. During the surveillance of mpox, we encountered cases of Varicella Zoster Virus (VZV) in suspected mpox cases amongst c
Externí odkaz:
https://doaj.org/article/f610e50478294b06ad5a77d3a399e902
Publikováno v:
National Journal of Laboratory Medicine, Vol 11, Iss 01, Pp 01-05 (2022)
Introduction: Coronavirus Disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) catapulted the need to build, upgrade and expand the number of diagnostic laboratories having molecular capacity. Setting
Externí odkaz:
https://doaj.org/article/de5da69074524728b91804e1f353ab4c
Autor:
Shubhada Shenai, Gita Nataraj, Minal Jinwal, Akhil S Thekke Purakkal, Rajashree Sen, Nayana Ingole, Trupti Mathure, Sanjay Sarin, Sarabjit S Chadha
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291269 (2023)
BackgroundTata MD CHECK SARS-CoV-2 kit 1.0, a CRISPR based reverse transcription PCR (TMC-CRISPR) test was approved by Indian Council of Medical Research (ICMR) for COVID-19 diagnosis in India. To determine the potential for rapid roll-out of this te
Externí odkaz:
https://doaj.org/article/96ef887c715244b281febcb41d06c7bc
Autor:
Chinmay Laxmeshwar, Shrikala Acharya, Mrinalini Das, Padmaja Keskar, Amar Pazare, Nayana Ingole, Preeti Mehta, Pooja Gori, Homa Mansoor, Stobdan Kalon, Pramila Singh, Taanya Mathur, Gabriella Ferlazzo, Petros Isaakidis
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232576 (2020)
BACKGROUND:Routine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living with HIV/AIDS (PLHA) on anti-retroviral therapy (ART). The Mumbai Districts AIDS Co
Externí odkaz:
https://doaj.org/article/256a07ee677240c9b642c2946a0cff2b
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 13, Iss 6, Pp DC01-DC04 (2019)
Introduction: Cryptococcal infection is the most common opportunistic fungal infection was seen in HIV patients. Despite specific treatment, mortality due to cryptococcaemia still remains high primarily because of late diagnosis. Therefore, studies h
Externí odkaz:
https://doaj.org/article/f9999e6c8edb478bacc058a80b5ce72d
Publikováno v:
Journal of Evolution of Medical and Dental Sciences. 9:961-964
Autor:
Ranjana, Thate, Nayana, Ingole, Vaishali Solanke, Surase, Kavita, Joshi, Smrati, Bajpai, Shrikala, Acharya, Gita, Nataraj
Publikováno v:
The Journal of the Association of Physicians of India. 69(12)
Targeted HIV 1 viral load testing has been recommended in 2010 only for suspected cases of antiretroviral therapy failure. India is committed to achieve UNAIDS '90-90-90' target by 2020. The third 90 target was to ensure all people receiving antiretr
Publikováno v:
The Indian Journal of Medical Research
Background & objectives: Immunocompromised individuals mainly HIV infected patients are at a great risk for developing toxoplasmosis. The presence of toxoplasmosis among HIV-infected patients directly correlates with the prevalence of anti- Toxoplasm